Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species DOI Creative Commons
Leira Fernández‐Bastit, Sílvia Marfil, Edwards Pradenas

et al.

Viruses, Journal Year: 2025, Volume and Issue: 17(5), P. 716 - 716

Published: May 16, 2025

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the disease 19 (COVID-19) pandemic, significantly impacting global health, economies, and social stability. In February 2020, first cases of SARS-CoV-2 infections in animals were documented, highlighting potential risks posed by regular human-animal interactions facilitating viral transmission. consequence, it is essential to validate surveillance methods for animals. present study, 101 sera from different animal species (36 cats, 41 dogs, 4 ferrets, 10 wild boar, 6 domestic goats, lions) tested using three ELISA kits evaluate humoral responses against SARS-CoV-2. results compared correlated with a pseudovirus neutralization test (pVNT), considered as reference assay. ELISA-1, targeting receptor binding domain (RBD) neutralizing antibodies (nAbs) SARS-CoV-2, exhibited highest diagnostic performance, proved be reliable tool initial screenings high-throughput studies. contrast, ELISA-2 (also RBD nAbs) ELISA-3 (targeting nucleoprotein antibodies) demonstrated lower sensitivity detecting seropositive

Language: Английский

Infectious potential and circulation of SARS-CoV-2 in wild rats DOI Creative Commons

Kevyn Beissat,

Virginie Lattard, Evelyne Picard‐Meyer

et al.

PLoS ONE, Journal Year: 2025, Volume and Issue: 20(5), P. e0316882 - e0316882

Published: May 12, 2025

Since the beginning of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, a wide range animal species (pets, mink…) have been naturally infected with this betacoronavirus. The emergence new variants has increased ability SARS-CoV-2 to infect that were not susceptible “original” SARS-CoV-2, such as mice and rats. This work attempted evaluate role urban rats in transmission by combining surveillance studies rat populations environments, vivo experimental inoculation comparative viral-receptor interaction silico analyses. We studied circulation wild Rattus norvegicus (n = 401) captured areas sewage systems several French cities. Except for 3 inconclusive samples (2/75 from Bordeaux 1/261 Lyon) none 353 sera tested showed anti-SARS-CoV-2 antibodies microsphere immunoassay. However, negative virus neutralisation assay. No viral RNA was detected all lungs collected 401 brown In complement, four groups (two wild-type colonies, rattus , two laboratory strains, Sprague-Dawley Wistar) inoculated Omicron BA.5. At 4 days post-inoculation, no infectious particles upper tract (URT) while at low level only URT groups. addition, seroconversion observed 14 after By molecular modelling, BA.5 receptor binding domain (RBD) had lower affinities ACE2 than Homo sapiens ACE2. Based on these results unable type study different France SARS-CoV-2.

Language: Английский

Citations

0

Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species DOI Creative Commons
Leira Fernández‐Bastit, Sílvia Marfil, Edwards Pradenas

et al.

Viruses, Journal Year: 2025, Volume and Issue: 17(5), P. 716 - 716

Published: May 16, 2025

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the disease 19 (COVID-19) pandemic, significantly impacting global health, economies, and social stability. In February 2020, first cases of SARS-CoV-2 infections in animals were documented, highlighting potential risks posed by regular human-animal interactions facilitating viral transmission. consequence, it is essential to validate surveillance methods for animals. present study, 101 sera from different animal species (36 cats, 41 dogs, 4 ferrets, 10 wild boar, 6 domestic goats, lions) tested using three ELISA kits evaluate humoral responses against SARS-CoV-2. results compared correlated with a pseudovirus neutralization test (pVNT), considered as reference assay. ELISA-1, targeting receptor binding domain (RBD) neutralizing antibodies (nAbs) SARS-CoV-2, exhibited highest diagnostic performance, proved be reliable tool initial screenings high-throughput studies. contrast, ELISA-2 (also RBD nAbs) ELISA-3 (targeting nucleoprotein antibodies) demonstrated lower sensitivity detecting seropositive

Language: Английский

Citations

0